Ezolid IV Infusion 2 mg/ml 300 ml solution

Ezolid is indicated for the treatment of: Nosocomial pneumonia Community-acquired pneumonia Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis Uncomplicated skin and skin structure infections Vancomycin-resistant Enterococcus faecium infections Limitations of use: Ezolid is not indicated for the treatment of Gram-negative infections. The safety and efficacy of Ezolid given for longer than 28 days have not been evaluated in controlled clinical trials.